Kiniksa Pharmaceuticals Intern
COM
CUSIP: G5269C101
FIGI: BBG00KT2KFX7
Institutional Holders1
Total Institutional Value$889
Total Shares Held21,543
Avg Position$889
Top 5 Holders %100.0%
Alpha-Weighted Score57.0
New Positions+0
Exited Positions-2
Top 15 Institutional Holders by Value
■ New ■ Increased ■ Decreased ■ Unchanged
Institutional Holders — Q4 25
| Manager | Alpha | Flow | Value | Shares | Change |
|---|---|---|---|---|---|
| HARBOR CAPITAL ADVISORS, INC. | Moderate Conviction | Low Flow | $889 (100.0%) | 21,543 | 10.6% |
Implied Institutional Price History
Estimated from 13F aggregate market value ÷ shares reported across all institutional filers. Reflects quarter-end snapshot, not actual trade prices.
| Quarter | Filers | Institutional Value | Shares Held | Est. Avg Price |
|---|---|---|---|---|
| Q4 25 | 1 | $0.00B | 21,543 | $0.04 |
| Q3 25 | 3 | $0.00B | 189,140 | $18.40 |
| Q2 25 | 2 | $0.00B | 100,926 | $8.24 |
| Q1 25 | 3 | $0.00B | 109,091 | $6.13 |
| Q4 24 | 2 | $0.00B | 158,093 | $7.52 |
| Q3 24 | 2 | $0.00B | 157,543 | $9.53 |
| Q2 24 | 5 | $0.00B | 96,788 | $11.87 |
| Q1 24 | 154 | $0.82B | 42,119,047 | $19.40 |
Source: SEC 13F-HR filings. Implied price = aggregate market value ÷ shares reported. Not investment advice.